Brain Stem CancerSymptoms, Doctors, Treatments, Advances & More
Brain Stem Cancer Overview
Learn About Brain Stem Cancer
Duke Cancer Center Brain Tumor Clinic
Allan Friedman is a Neurosurgery provider practicing medicine in Durham, North Carolina. Dr. Friedman is rated as a Distinguished provider by MediFind in the treatment of Brain Stem Cancer. He is also highly rated in 43 other conditions, according to our data. His clinical expertise encompasses Glioma, Astrocytoma, Glioblastoma, Awake Craniotomy, and Spinal Fusion. Dr. Friedman is board certified in American Board Of Neurological Surgery, Neurological Surgery. Dr. Friedman is currently accepting new patients.
Ricardo Komotar is an Oncologist and a Neurosurgery provider practicing medicine in Miami, Florida. Dr. Komotar is rated as a Distinguished provider by MediFind in the treatment of Brain Stem Cancer. He is also highly rated in 57 other conditions, according to our data. His clinical expertise encompasses Brain Tumor, Meningioma, Glioblastoma, Awake Craniotomy, and Posterior Fossa Decompression. Dr. Komotar is currently accepting new patients.
OSF Illinois Neurological Institute - Neurosurgery
Andrew Tsung is a Neurosurgery provider practicing medicine in Urbana, Illinois. Dr. Tsung is rated as a Distinguished provider by MediFind in the treatment of Brain Stem Cancer. He is also highly rated in 47 other conditions, according to our data. His clinical expertise encompasses Glioblastoma, Astrocytoma, Glioma, Awake Craniotomy, and Gamma Knife Radiosurgery. Dr. Tsung is board certified in American Board Of Neurological Surgery. Dr. Tsung is currently accepting new patients.
Summary: This phase I/II trial evaluates the best dose, side effects and possible benefit of CBL0137 in treating patients with solid tumors, including central nervous system (CNS) tumors or lymphoma that has come back (relapsed) or does not respond to treatment (refractory). Drugs, such as CBL0137, block signals passed from one molecule to another inside a cell. Blocking these signals can affect many funct...
Summary: This study will address the question of whether targeting CMV antigens with PEP-CMV can serve as a novel immunotherapeutic approach in pediatric patients with newly-diagnosed high-grade glioma (HGG) or diffuse intrinsic pontine glioma (DIPG) as well as recurrent medulloblastoma (MB). PEP-CMV is a vaccine mixture of a peptide referred to as Component A. Component A is a synthetic long peptide (SLP)...

Keep Punching supports patients, healthcare providers, and researchers in their fight to prevent and eradicate brain cancer and minimize treatment-related side effects that may adversely impact function and comfort.


